TipRanks
Go Ultimate55% OFF

Petlife Pharmaceuticals (PTLF) Financial Statements

Petlife Pharmaceuticals Financial Overview

Petlife Pharmaceuticals's market cap is currently $22.43K. The company's EPS TTM is $-0.03; its P/E ratio is 0.00; Petlife Pharmaceuticals has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Aug 17
Income Statement
Total Revenue$ 0.00
Gross Profit$ 0.00
Operating Income$ -22.66M
EBITDA$ -22.87M
Net Income$ -23.26M
Balance Sheet
Cash & Short-Term Investments$ 54.25K
Total Assets$ 55.00K
Total Debt$ 717.18K
Net Debt$ 662.92K
Total Liabilities$ 1.44M
Stockholders' Equity$ -1.38M
Cash Flow
Free Cash Flow$ -318.92K
Operating Cash Flow$ -318.92K
Investing Cash Flow$ 0.00
Financing Cash Flow$ 372.00K

Currency in USD

Petlife Pharmaceuticals Earnings and Revenue History

-30M-20M-10M00 %0.4 %0.8 %1.2 %EarningsProfit Margin2017RevenueEarningsProfit Margin

Petlife Pharmaceuticals Debt to Assets

0600K1.2M1.8M2610 %2611 %2612 %2613 %LiabilitiesDebt to Assets2017AssetsLiabilitiesDebt to Assets

Petlife Pharmaceuticals Cash Flow

-400K-200K0200K400K600K2017OperatingInvestingFinancing

Petlife Pharmaceuticals Forecast EPS vs Actual EPS